
Jasoquin300 mg
Jayson Pharma Ltd.
Quinine Sulfate is an antimalarial agent (cinchona alkaloid) with the following indications: Established / FDA-Approved Use Uncomplicated chloroquine-resistant Plasmodium falciparum malaria: Quinine…
Quinine Sulfate is an antimalarial agent (cinchona alkaloid) with the following indications:
Important: Quinine Sulfate is not used for malaria prophylaxis (prevention) and is not effective as monotherapy for falciparum malaria in most regions due to resistance concerns.
Quinine Sulfate is administered orally and dosed according to indication and patient weight. It is essential to complete the full prescribed course, taken in combination with the partner drug specified by the treating physician, exactly as prescribed.
| Population | Dose | Duration | Typically Combined With |
|---|---|---|---|
| Adults | 648 mg (salt) orally every 8 hours | 3–7 days depending on region of acquisition (longer courses, e.g. 7 days, for infections acquired in Southeast Asia) | Doxycycline, tetracycline, or clindamycin |
| Children | Approximately 8.3 mg/kg (salt) orally every 8 hours (weight-based; not to exceed adult dose) | 3–7 days as above | Clindamycin (preferred in young children and pregnant women, as doxycycline/tetracycline are generally avoided) |
Renal impairment: Dose reduction and close monitoring are recommended in patients with significant renal impairment, as drug accumulation may increase toxicity risk; consult a physician for individualized adjustment.
Hepatic impairment: Use with caution and consider dose adjustment, as Quinine Sulfate undergoes hepatic metabolism.
Quinine Sulfate must be taken exactly as prescribed by a physician; do not stop, extend, skip doses, or share this medicine with others without medical advice, as inadequate treatment can promote parasite resistance and treatment failure.
Dose-related "cinchonism" is common with Quinine Sulfate and includes: tinnitus, headache, nausea, vomiting, abdominal discomfort, and mild visual disturbances. These effects are usually reversible with dose reduction or discontinuation.
Patients should seek immediate medical attention for unusual bruising/bleeding, dark urine, decreased urination, severe dizziness, palpitations, or signs of allergic reaction.
Quinine Sulfate is contraindicated in patients with:
Quinine Sulfate should not be used for the treatment or prevention of nocturnal leg cramps (see Precautions and Warnings).
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.